AUTHOR=Puertas Borja , Rey-Búa Beatriz , Eiros Rocío , Martín-Arribas Alberto , Montero-Mateos Enrique , Hernández-Sánchez Alberto , Gómez-Úbeda Sandra , Alejo-Alonso Elena , Martín-López Ana A. , Antúnez Patricia , Villacorta-Argüelles Eduardo , Gallego-Delgado María , Puig Noemi , Mateos María-Victoria , González-Calle Verónica TITLE=Case Report: Renal relapse after heart transplantation, induction, and autologous stem cell transplantation in a patient with AL amyloidosis with exclusive cardiac involvement JOURNAL=Frontiers in Hematology VOLUME=1 YEAR=2022 URL=https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2022.997262 DOI=10.3389/frhem.2022.997262 ISSN=2813-3935 ABSTRACT=
There is no recommendation on what salvage therapy is optimal in the solid organ recipient with AL amyloidosis, such as a heart transplant. With this case, we illustrate how treatment with daratumumab may be effective and safe in a patient with AL amyloidosis with renal involvement at the relapse after heart transplantation and autologous stem cell transplantation.